The company is preparing a blood-based test for early-stage pancreatic cancer that it hopes to have on the market by 2019.
The firm is investing in studies that use its multiplex microarray platform to monitor lupus disease activity and traumatic brain injury response.
The sensor features a DNA-based steric hindrance method, and can detect the presence of antibodies in whole blood in less than 10 minutes.
NEW YORK (GenomeWeb News) – Myriad Genetics today said that its Myriad RBM subsidiary has formed a research collaboration with DaVita Labs to discover protein-based biomarkers that could be used to benefit dialysis patients.
NEW YORK (GenomeWeb News) – Irvine, Calif.-based Aviir announced yesterday that it has raised $10 million in a second tranche of a private financing round.
The collaboration will combine Metamark's multiplex protein detection platform with image analysis technology that the firm will jointly develop with Definiens.
The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.
Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.
In Science this week: in vitro generation of human reproductive cells, and more.
Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.